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Coronavirus disease 2019 (COVID-19) is a condition caused by a novel virus, 
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The disease’s 
course ranges from entirely asymptomatic to severely ill patients. Hypercoagu-
lation is often a complication of this disease, worsening the prognosis, which is 
extremely important in patients at higher risk of thromboembolic events, such 
as atrial fibrillation (AF), where thrombus formation in the left atrial appendage 
(LAA) is frequent. LAA could be of various sizes, volumes, and shapes, distinguish 
several morphologies, from which the WindSock LAA is the most frequent. In 
contrast, thromboembolic complications occur most frequently in patients with 
AF and the Cactus LAA. We present a clinical case of a 70-year-old woman with 
an initial negative real-time polymerase chain reaction (RT-PCR) test for SARS- 
-CoV-2, suspicion of device-related infection after dual pacemaker implantation, 
AF, and LAA without thrombus in the initial transoesophageal echocardiography 
(TEE). Despite apixaban treatment, spontaneous restoration of sinus rhythm, and 
WindSock LAA morphology, the sludge in LAA was diagnosed in control TEE. The 
patient did not present any typical clinical COVID-19 symptoms but re-checked 
the RT-PCR test for SARS-CoV-2 infection was positive. The described case presents 
echocardiographic evidence of hypercoagulation as the first and only feature 
of SARS-CoV-2 condition besides the usual morphological presentation of the 
WindSock LAA. (Folia Morphol 2021; 80, 3: 714–717)
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INTRODUCTION
Coronavirus disease 2019 (COVID-19) is a condi-
tion caused by a novel virus, severe acute respirato-
ry syndrome coronavirus 2 (SARS-CoV-2) [10]. The 
real-time polymerase chain reaction (RT-PCR) test 
is the most reliable in diagnosing COVID-19. The 
disease’s course ranges from entirely asymptomatic 
to severely ill patients. Hypercoagulation is often 
a complication of this disease, worsening the prog-
nosis [3]. This complication seems to be aggravated 
in patients at higher risk of thromboembolic events, 
such as patients with atrial fibrillation (AF), in whom 
a thrombus formation in the left atrial appendage 
(LAA) is frequent. Additional factors that increase 
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the risk of formation of thrombus in the LAA are the 
specific anatomy of the LAA and the low left ventric-
ular ejection fraction. We present a clinical case that 
presents SARS-CoV-2 infection as an additional cause 
of LAA thrombus formation.  
CASE PRESENTATION
A 70-year-old woman with AF and negative RT-
-PCR test for SARS-CoV-2 was transferred from the 
district hospital to the Cardiology Department with 
suspicion of device-related infection after dual pace-
maker implantation, performed 1 week before the 
admission. Additionally, the urinary tract infection 
was diagnosed, and empirical antimicrobial therapy 
was initiated, leading to a quick reduction of inflam-
matory markers. There were no pathologies connect-
ed with ventricle lead; however, in transoesophageal 
echocardiography (TEE), using two- and three-di-
mensional techniques, linear echoes associated with 
the atrial electrode were visualised (Fig. 1A). Due to 
the short time after the implantation and negative 
blood culture results, the thrombus was anticipated, 
Figure 1. The figures visualise the image in transoesophageal echocardiography performed twice in the described patient. On admission to 
the Cardiology Department, the patient had linear echoes on the atrial electrode (panel A — arrows) and a clean left atrial appendage (LAA) 
(panel B — arrow). In a follow-up study after the spontaneous return of sinus rhythm and a week of apixaban (5 mg BID) therapy, the linear 
echoes on the atrial lead disappeared, while the left atrium filled with highly hyperechogenic blood (panel C — arrow) and LAA with the 
sludge (panel D — arrow) were visualised. Additionally, the long persistence of the bubbles of midazolam in the right atrium was observed 
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of 2 (54%) lobes, the second most frequent are an LAA 
with 3 (23%) lobes, then with 1 (20%) lobe and the least 
frequent is the presence of 4 (3%) lobes. The orifice of 
the LAA leads through the neck to the central append-
age cavity, which can have a different shape depending 
on the type of an LAA. According to Wang et al. [12], the 
most frequent LAA anatomy is the WindSock LAA (Fig. 
2A), which has no obvious bands, and one dominant 
lobe of sufficient length is the basic structure. Variations 
of this type of LAA appear with the different locations 
and number of secondary lobes descending downward 
from the dominant lobe. The second most frequent 
anatomy is the Cauliflower LAA (Fig. 2C), which, like 
the previous type, does not have obvious bands; an LAA 
is characterized by a limited overall length and more 
complex internal features. Its varieties are described by 
a more irregular shape of the orifice of the LAA, the 
number of significant lobes, and the lack of the dom-
inant lobe. The ChickenWing LAA (Fig. 2B) is the third 
most common type; the main feature of that type of 
LAA is an obvious band in the proximal or middle part 
of the dominant lobe or a backward fold of the LAA at 
some distance from the orifice of the LAA. This type may 
differ in the presence or absence of additional lobes or 
twigs, with a different measured distance to this bend, 
and with different orientations of the bends to the main 
lobe. The last most common type is the Cactus LAA 
(Fig. 2D); its main feature is the dominant lobe with 
secondary lobes extending from the dominant lobe to 
the superior and inferior directions [12].
According to the literature, thromboembolic com-
plications occur most frequently in patients with AF 
and the Cactus LAA [4]. Additionally, the small size 
of LAA, the presence of secondary lobes, the narrow 
orifice of the LAA, and excessive trabeculations result 
in low LAA peak flow velocities that could significantly 
increase the risk of thrombus formation LAA [1]. It 
should also be emphasized that the large size of the 
left atrium and the reduced left ventricular ejection 
fraction are additional risk factors for the develop-
ment of thromboembolic complications.
In the described case, we presented echocardi-
ographic evidence of hypercoagulation as the first 
and only feature of SARS-CoV-2 infection in the usual 
morphological presentation of the WindSock LAA 
(Fig. 1F). Despite the use of apixaban treatment, the 
lack of features promoting thrombus formation in 
the LAA (Fig. 1D), such as excessive trabeculations, 
a narrow junction of the proximal lobe of the LAA, 
a narrow junction between the distal lobe of the LAA 
A
Figure 2. General scheme showing the four most common 
types of the left atrial appendage (LAA); A. The WindSock 
LAA; B. The ChickenWing LAA; C. The Cauliflower LAA;  
D. The Cactus LAA.
B
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not bacterial vegetation. The LAA had typical mor-
phology and sizes, as presented in Figure 1. Despite 
AF, there was no sludge or thrombus in the LAA 
(Fig. 1B). The spontaneous restoration of sinus rhythm 
was observed. The treatment with apixaban (5 mg 
BID) was initiated, and empirical antibiotic therapy 
was continued. After 1 week of the treatment, TEE 
was repeated with no linear echoes within the atri-
al electrode. Interestingly, despite permanent sinus 
rhythm and anticoagulation therapy with apixaban, 
the left atrium was filled with highly hyperechogenic 
blood (Fig. 1C) and the LAA with a sludge (Fig. 1D). 
Moreover, the long persistence of the bubbles of 
midazolam in the right atrium has been observed 
(Fig. 1E). The patient did not present any typical clin-
ical COVID-19 symptoms [2], but had neutropenia, 
lymphopenia, low procalcitonin, hypoalbuminaemia, 
and increased C-reactive protein. We re-checked the 
RT-PCR test for SARS-CoV-2 infection, and the result 
was positive. 
DISCUSSION
The LAA lies within the pericardium, in the left 
atrioventricular sulcus atop the left circumflex artery’s 
proximal part and extends between the anterior and 
the lateral walls of the LA near the left pulmonary veins 
[11]. The LAA could be of various sizes, volumes, and 
shapes and often has several lobes [5, 8, 11]. Veinot et 
al. [11] found that the most common is the presence 
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and its proximal lobe, or the presence of additional 
LAA lobes, there has been a sludge in the LAA. The 
coagulation abnormalities in COVID-19 are postulated 
to result from acute inflammation in the organism 
and increased activity of inflammatory mediators [7]. 
The urinary tract infection could additionally attenu-
ate the hypercoagulation status in our patient.
CONCLUSIONS
The connection between hypercoagulation 
features and COVID-19 in a patient without other 
typical infection indicators seems to be particular-
ly difficult, as in the presented case. Based on the 
available literature about COVID-19 management, 
low-molecular-weight heparin should be considered 
for thromboembolic complications prophylaxis [6]. 
In contrast, oral anticoagulant therapy is not recom-
mended due to its limited effectiveness, confirmed 
in our patient. The LAA in the case presented above 
did not show any features predisposing to thrombus 
formation; the LAA was of standard size and not 
narrow. Besides, a thrombus developed despite the 
patient’s persistent sinus rhythm and anticoagu-
lant treatment, which suggests a hypercoagulability 
state in the course of COVID-19. The presented case 
additionally shows that a negative test for SARS-
CoV-2 infection does not always give a full guarantee 
that the patient is not infected, and the patient’s 
clinical manifestation should be taken into account 
in further clinical decisions. It is worth emphasizing 
that modern echocardiography, including three-di-
mensional techniques, can be recognised as a part 
of comprehensive imaging technology that could be 
helpful in COVID-19 diagnosis [9].
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